What Has Been The Historical And Current Growth Of The Biotechnology Services Market?
The biotechnology services market has seen considerable growth due to a variety of factors.
• The market size of biotechnology services has seen consistent expansion in the past few years. It is projected to augment from a worth of $133.74 billion in 2024 to an estimated $140.24 billion in 2025, progressing at a compound annual growth rate (CAGR) of 4.9%.
The notable growth during the prior period can be credited to robust economic enhancements in developing markets, escalated partnerships with various research institutions and firms, as well as a rise in the demand for food.
How Will The Biotechnology Services Market Size Evolve In The Foreseeable Future?
The biotechnology services market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the biotechnology services market is anticipated to experience robust growth, expanding to a size of $171.87 billion in 2029, with a compound annual growth rate (CAGR) of 5.2%.
This growth during the predicted period can be credited to rapid technological advances, an increase in non-communicable diseases, a focus on innovation, soaring demand for biotechnology services in agriculture, a surge in demand for synthetic biology, advancements in drug research, growth in personalised treatments, and collaborative partnerships. Key trends for this forecast period comprise strategic alliances, the incorporation of data management systems via cloud technology, the advancement of next-generation sequencing technology, the application of digitalisation techniques in conducting clinical trials, the adoption of automated solutions, the implementation of artificial intelligence technologies, and investments in synthetic biology for product and solution development.
What Are the Critical Driver Fuelling the Biotechnology Services Market's Growth?
The escalating prevalence of diseases such as hepatitis B, diabetes, and cancer is propelling biotechnology research. Biotechnology leverages tools from biology and chemistry to examine the genetic composition of bacteria and viruses to scrutinize the agents causing diseases. Cancer research is incredibly prominent among biopharmaceutical companies. Progress is being made on stem cell treatments using monoclonal antibody therapies and genomic sequencing in medical applications. For example, the UK's National Health Service reported in June 2024 that over half a million additional individuals (549,000) in England were identified as being at risk of developing type 2 diabetes in 2023, which brings the total number of non-diabetic hyperglycemia or pre-diabetes registered with a GP to 3,615,330. This is a significant leap compared to the 3,065,825 recorded in 2022, indicating an increase of nearly 20%. Additionally, according to the World Health Organization, a Switzerland-based intergovernmental organization, it was projected in February 2024 that over 35 million new cancer cases would be recorded by 2050. This figure represented a staggering 77% leap compared to the estimated 20 million cases in 2022. Consequently, the burgeoning prevalence of diseases and massive expenditure on R&D are expected to stimulate the growth of the biotechnology services market.
What Are The Core Segments Of The Globa Biotechnology Services Market?
The biotechnology services market covered in this report is segmented –
1) By Service: Prevention And Disease Control, Public Engagement Activities, Health Education And Research, Food Biotechnology Services, Donor Recruitment, Tissue Collection, Cell Processing And Isolation, Research And Development
2) By Industry: Clinical Research Organizations (CROS), Contract Manufacturers Organizations (CMOS), And Contract Research And Manufacturing Services (CRAMS)
3) By Area Of Application: Pharmaceutical, Biotechnology, Academic, Clinical Trial, Healthcare Sectors, Others
Subsegments:
1) By Prevention And Disease Control: Vaccination Services, Disease Surveillance
2) By Public Engagement Activities: Awareness Campaigns, Community Outreach Programs
3) By Health Education And Research: Medical Training Programs, Research Grants And Fellowships
4) By Food Biotechnology Services: Genetically Modified Crop Services, Food Safety Testing
5) By Donor Recruitment: Blood Donor Recruitment, Organ Donor Recruitment
6) By Tissue Collection: Blood Tissue Collection, Biopsy Tissue Collection
7) By Cell Processing And Isolation: Stem Cell Processing, Immune Cell Isolation
8) By Research And Development: Drug Discovery Services, Clinical Research
Pre-Book The Biotechnology Services Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Trends Are Reshaping The Biotechnology Services Market Size?
Alliances and affiliations among industry stakeholders are becoming increasingly common in the area of biotech services. For example, in April 2024, ICL partners, a production business based in Israel, joined forces with Ideelab Biotechnology, a Brazilian biotech firm, to expedite the innovation of cutting-edge biological technologies for farming, emphasising sustainable and regenerative solutions. By utilising Ideelab's proficiency in sophisticated biologicals and ICL's command over plant nutrition and physiology, the partnership aims to develop future-oriented products that can tackle worldwide agricultural issues and boost food production.
Who Are the Key Players in the Biotechnology Services Market?
Major companies operating in the biotechnology services market include:
• Parexel International Corporation
• Thermo Fisher Scientific
• Laboratory Corporation of America Holdings
• IQVIA
• ICON plc
• Charles River Laboratories
• Syneos Health
• Sartorius AG
• Precision for Medicine Inc.
• Novartis
• Eppendorf Asia Pacific Sdn. Bhd.
• Emmessar Biotech & Nutrition Ltd
• Vcanbio Cell & Gene Engineering Corp. Ltd
• Ke Rui Gene
• Absea Biotechnology Ltd
• CStone Pharm-B
• Daiichi Sankyo
• bitBiome
• Taisho Pharmaceutical
• AGC Biologics
• Hamamatsu Pharma Research
• Artios Pharma
• AstraZeneca
• Bio Products Laboratory (BPL)
• Cambridge Bioscience
• Shire Pharmaceuticals Ltd
• BTG Ltd
• eXmoor Pharma
• 4D Pharma PLC
• Touchlight Genetics
• Ophidia Medical Technologies
• ATAI Life Sciences
• Phaseform
• Evotec
• Sanity Group
• Primmbiotech Vaccitech
• Biolat
• Asla-Biotech
• Genera
• Anima Lab
• Silvanols
• OU TBD-Biodiscovery
• Qvalitas Arstikeskus AS
• Concise Systems OU
• GPE Globalpharma OU
• Belarusian National Biotechnology Corporation
• Innothera
• Olainfarm
• Pharmaidea
• Amgen Inc.
• Gilead Sciences
• Celgene Corporation
• Biogen Inc.
• Vertex Pharmaceuticals
• Illumina. Inc.
• Regeneron Pharmaceuticals Inc.
• Alexion Pharmaceuticals
• Hemostemix Inc.
• Resverlogix Corporation
• Zenith Epigenetics Corp.
• Bayer
• AMEGA Biotech
• Pierre Fabre
• Pfizer
• Quantificare
• Apsen Farmaceutica
• BioMarin Pharmaceutical
• DK Diagnostics
• Biosonda Biotechnology
• Laboratorios Legrand
• Biomerics
• Julphar Pharmaceuticals
• Medpharma
• Pharmax
• Neopharma
• City Breeze Technical Services
• CinnaGen
• BioSun Pharmed
• AryoGen Pharmed
• 4Clinics
• 54gene
• Amoun
• Aspen Pharmacare
• BBI Solutions
• BioTech Africa
• ClinArt MENA
• Crux Pharmaceuticals
• Genesis Pharmaceuticals
• Massive Genomics
• Mayne Pharma
• Sanofi Genzyme
• Teleflex Medical
• The Micron Group
What are the Regional Insights into the Biotechnology Services Market?
Asia-Pacific was the largest region in the biotechnology services market in 2024. North America was the second largest region in the global biotechnology services market analysis. The regions covered in the biotechnology services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
